We are looking for investigators interested in recruiting cancer patients in the indications of interest for IMMUcan.
Patients will be recruited via SPECTA, the integrated research infrastructure under EORTC legal sponsorship. Once you become an authorized investigator within the platform, you will be able to recruit patients in all opened cohorts, including the IMMUcan’s ones.
Check here for more information about SPECTA.
Information on IMMUcan cohorts and patients’ eligibility criteria can be found from the SPECTA website.